Cargando…
Dengue vaccine development by the year 2020: challenges and prospects
The first licensed dengue vaccine led to considerable controversy, and to date, no dengue vaccine is in widespread use. All three leading dengue vaccine candidates are live attenuated vaccines, with the main difference between them being the type of backbone and the extent of chimerization. While CY...
Autor principal: | Wilder-Smith, Annelies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568693/ https://www.ncbi.nlm.nih.gov/pubmed/33086187 http://dx.doi.org/10.1016/j.coviro.2020.09.004 |
Ejemplares similares
-
Dengue: Challenges for Policy Makers and Vaccine Developers
por: Wilder-Smith, Annelies, et al.
Publicado: (2014) -
Dengue vaccine development: status and future
por: Wilder-Smith, Annelies
Publicado: (2019) -
Optimising dengue pre-vaccination screening
por: Wilder-Smith, Annelies, et al.
Publicado: (2021) -
Dengue infections in travellers
por: Wilder-Smith, Annelies
Publicado: (2012) -
Epidemiology of dengue: past, present and future prospects
por: Murray, Natasha Evelyn Anne, et al.
Publicado: (2013)